Delivery Order SPE2DB20D3101-SPE2DB22FH2A0

Award Date 11/30/21
Potential Completion Date 12/1/21
Potential Value $1.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,206.16 firm fixed-price delivery order is for the supply of 250 count tablets of the pharmaceutical product Mercaptopurine 50 mg. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,743.60 for the supply of 4559340000 - Azathioprine 50 mg Tablets in 100-count bottles. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of December 12, 2022. The contract type is Firm Fixed Price, and there was no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order with a Firm Fixed Price valued at $1,229.53. The contract was awarded by the Defense Logistics Agency (DLA) for pharmaceutical and medical supply services. It has an ultimate completion date of January 15, 2021 and was awarded on January 14, 2021. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp, as a major...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB20D2104|SPE2DB24FT00S) valued at $1,182.71 for pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,268.30, is for the delivery of Mycophenolate 200 mg/ml suspension in 160 ml bottles. The contract is a delivery order with a firm-fixed price and has an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $18,037.39 for the supply of 4563017688 ! MULTAQ 400 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was granted to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an award value of $1,126.99 and was issued by the Defense Logistics Agency (DLA), a defense agency. The contract is for pharmaceutical and medical supply products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DB20D2104|SPE2DB21FT04P) valued at $1,199.40. The contract was awarded by the Defense Logistics Agency (DLA) to provide pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is not designated with a set-aside and was awarded through full and open competition....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,290.00 for pharmaceutical and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $1,020.84 for the pharmaceutical product MYORISAN 40 MG CAPSULE 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB22FH2A0
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DB22FH2A0) valued at $1,493.20 for the supply of 4555553872 MERCAPTOPURINE 50 MG TABLET 250S. The contract was awarded on November 30, 2021, with a completion date of December 1, 2021.

The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 10:01 AM